Product details
The BD Veritor™ System for Rapid Detection of Flu A+B (CLIA-Waived Kit) is designed to provide fast, accurate identification of influenza A and influenza B viruses at the point of care. Manufactured by BD, this system supports timely clinical decisions during flu season and respiratory illness outbreaks.
Using advanced digital immunoassay technology, the BD Veritor™ System delivers clear, objective results that help reduce subjectivity associated with visually read rapid tests. Rapid turnaround time enables clinicians to quickly differentiate influenza from other respiratory conditions and guide appropriate patient management.
The CLIA-waived format allows testing to be performed in physician offices, urgent care centers, clinics, emergency departments, and other near-patient settings, without the need for complex laboratory infrastructure.
The BD Veritor™ Plus System is a handheld device that enables testing for Flu A+B, Group A Strep, and respiratory syncytial virus (RSV) assays. One-button functionality and workflow flexibility allow the healthcare team to confidently use the device. In addition, the system’s fast and accurate results may help improve the patient experience. The BD Veritor™ Plus System streamlines the point-of-care testing experience.
Key Features:
-
Rapid detection of influenza A and influenza B
-
CLIA-waived for point-of-care testing
-
Digital immunoassay technology for objective result interpretation
-
Fast turnaround to support timely treatment decisions
-
Helps improve workflow efficiency in busy clinical settings
-
Suitable for outpatient, urgent care, and pediatric environments
